AVITA Medical Inc banner

AVITA Medical Inc
NASDAQ:RCEL

Watchlist Manager
AVITA Medical Inc Logo
AVITA Medical Inc
NASDAQ:RCEL
Watchlist
Price: 4.65 USD 5.68%
Market Cap: $143.1m

Wall St Price Targets

RCEL Price Targets Summary
AVITA Medical Inc

Wall Street analysts forecast RCEL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCEL is 4.93 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

Lowest Forecast
Price Target
3.03 USD
35% Downside
Average Forecast
Price Target
4.93 USD
6% Upside
Highest Forecast
Price Target
6.3 USD
35% Upside
AVITA Medical Inc Competitors:
Price Targets
LVO
LiveOne Inc
168% Upside
AMAL
Amalgamated Bank
-2% Downside
CNSP
CNS Pharmaceuticals Inc
75% Upside
AYTU
Aytu Biopharma Inc
329% Upside
VINP
Vinci Partners Investments Ltd
46% Upside
LAND
Gladstone Land Corp
41% Upside
SANA
Sana Biotechnology Inc
179% Upside
NSIT
Insight Enterprises Inc
-24% Downside

Revenue
Forecast

28% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
28% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 3 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 14%.

Gross Profit
Forecast

28% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
28% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 3 years, the compound annual growth rate for Gross Profit has been 28%. The projected CAGR for the next 8 years is 15%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RCEL's stock price target?
Price Target
4.93 USD

According to Wall Street analysts, the average 1-year price target for RCEL is 4.93 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

What is the Revenue forecast for AVITA Medical Inc?
Projected CAGR
14%

Over the last 3 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 14%.

What is the Gross Profit forecast for AVITA Medical Inc?
Projected CAGR
15%

Over the last 3 years, the compound annual growth rate for Gross Profit has been 28%. The projected CAGR for the next 8 years is 15%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett